TY  - JOUR 
AU  - Otto, S.
AU  - Jiménez Díaz, Victor Alfonso
AU  - Weilenmann, D.
AU  - Cuculi, F.
AU  - Nuruddin, A.A.
AU  - Leibundgut, G.
AU  - Alfonso, F.
AU  - Wan Ahmad, W.A.
AU  - Pyxaras, S.
AU  - Rittger, H.
AU  - Steen, P.
AU  - Gaede, L.
AU  - Schulze, C.
AU  - Wöhrle, J.
AU  - Rosenberg, M.
AU  - Waliszewski, M.W.
PY  - 2023
SN  - 1471-2261
UR  - http://hdl.handle.net/20.500.11940/21295
AB  - Background: A decade ago, the iopromide-paclitaxel coated balloon (iPCB) was added to the cardiologist's toolbox to initially treat in-stent restenosis followed by the treatment of de novo coronary lesions. In the meantime, DES technologies have been...
LA  - eng
KW  - Humans
KW  - Angioplasty
KW  - Cardiovascular Agents
KW  - Constriction, Pathologic
KW  - Coronary Artery Disease
KW  - Coronary Restenosis
KW  - Drug-Eluting Stents
KW  - Paclitaxel
KW  - Sirolimus
KW  - Treatment Outcome
KW  - Clinical Trials as Topic
TI  - Crystalline sirolimus-coated balloon (cSCB) angioplasty in an all-comers, patient population with stable and unstable coronary artery disease including chronic total occlusions: rationale, methodology and design of the SCORE trial
DO  - 10.1186/s12872-023-03187-x
T2  - BMC Cardiovascular Disorders
KW  - AS Vigo
KW  - CHUVI
VL  - 23
ER  -